Neurovisual rehabilitation with AvDesk®

Medical device Class I for neurovisual rehabilitation in telemedicine

About AvDesk®

AvDesk® is a class I medical device for the development of neurovisual rehabilitation therapies.

Born in 2010 from the multi-year work conducted by Linari Holding in collaboration with IRCCS Fondazione Stella Maris Pisa, a world leader in child neuropsychiatry, AvDesk® is a device protected by an international patent and uses cutting-edge technologies to work in telemedicine.

AvDesk® allows doctors and therapists to develop a personalized cognitive training program on a daily basis based on the needs of the person being treated, guaranteeing appreciable improvements already after two weeks of treatment.

bambina che sta per iniziare un trattamento con avdesk
immagine grafica sulla stimolazione audiovisiva

Operating principles

AvDesk® is a multisensory telerehabilitation device that uses brain plasticity to stimulate intact subcortical structures. A series of visual and sound signals are delivered through the stimulation panel, programmed according to sequences and temporal frequencies determined by a personalized therapy.

Application fields

unità di elaborazione dati del dispositivo di riabilitazione neurovisiva

Neurovisual rehabilitation device: who is it for?

Making use of the most modern artificial vision systems, AvDesk® is a device designed to offer doctors and health specialists a revolutionary rehabilitation approach in the treatment of children and adults with neurovisual deficits resulting from specific pathologies such as, for example, hemianopia and quadrantopsia.

Neurovisual rehabilitation in telemedicine

Compact, light and easy to carry, AvDesk® was designed to take advantage of the advantages offered by telemedicine and make it possible to use it directly at the home of the patient.

The device is equipped with an artificial intelligence system that guides and monitors the patient allowing him to maintain the attentional level and the correct position, in order to achieve correct therapeutic adherence. This allows you to use AvDesk® in the clinic or at your home, without the constant presence of a specialist doctor or therapist.

A Cloud space allows the doctor or therapist to consult the treatment protocol daily, download the reports relating to the patient's response times and create new protocols adapted to the progress of the therapy, setting parameters such as: sound intensity, position of the stimulus audiovisual, led color.

The data processing system on which the device is based allows to exploit the potential of teleconsultation. Specialists and experts in the health sector can consult, evaluate and modify therapies, adapting them to the course of treatment.

immagine di madre e figlia che svolgono da casa la terapia i riabilitazione neurovisiva
riabilitazione neurovisiva con avdesk svolta in ambulatorio

Practical and intuitive

AvDesk® is composed of a stimulation panel that can be rolled up on itself, light and easily foldable with one hand.
In its entirety, the device can be easily placed on a desk.

Thanks to the Tim card, supplied, the data processing unit is always connected to the internet. Plug and play start-up.

Choose AvDesk® according to your needs:

AvDesk® flexi: only in the clinic (without artificial intelligence).
AvDesk® flexi A.I.: only in the clinic (equipped with artificial intelligence).
AvDesk® travel: in the clinic and at home (equipped with artificial intelligence).

componenti di avdesk travel

Book a free consultation with an AvDesk® specialist for more details.

Information, images, descriptions and any data reported on the site concerning medical devices are not intended for promotion but as scientific material addressed exclusively to healthcare professionals. Therefore if keep surfing, the reader declares to be a Healthcare Professional. Reference: Ministry of Health – New guidelines for advertisement concerning medical devices, in vitro diagnostic and surgical medical devices of 28 March 2013; Update of the Guidelines on the use of new means of diffusion of healthcare advertising of 17 February 2010.